» Articles » PMID: 30655556

PD-1/PD-L1 Pathway Modulates Macrophage Susceptibility to Mycobacterium Tuberculosis Specific CD8 T Cell Induced Death

Overview
Journal Sci Rep
Specialty Science
Date 2019 Jan 19
PMID 30655556
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

CD8T cells contribute to tuberculosis (TB) infection control by inducing death of infected macrophages. Mycobacterium tuberculosis (Mtb) infection is associated with increased PD-1/PD-L1 expression and alternative activation of macrophages. We aimed to study the role of PD-1 pathway and macrophage polarization on Mtb-specific CD8T cell-induced macrophage death. We observed that both PD-L1 on CD14 cells and PD-1 on CD8T cells were highly expressed at the site of infection in pleurisy TB patients' effusion samples (PEMC). Moreover, a significant increase in CD8T cells' Mtb-specific degranulation from TB-PEMC vs. TB-PBMC was observed, which correlated with PD-1 and PDL-1 expression. In an in vitro model, M1 macrophages were more susceptible to Mtb-specific CD8T cells' cytotoxicity compared to M2a macrophages and involved the transfer of cytolytic effector molecules from CD8T lymphocytes to target cells. Additionally, PD-L1 blocking significantly increased the in vitro Ag-specific CD8T cell cytotoxicity against IFN-γ-activated macrophages but had no effect over cytotoxicity on IL-4 or IL-10-activated macrophages. Interestingly, PD-L1 blocking enhanced Mtb-specific CD8 T cell killing of CD14 cells from human tuberculous pleural effusion samples. Our data indicate that PD-1/PD-L1 pathway modulates antigen-specific cytotoxicity against M1 targets in-vitro and encourage the exploration of checkpoint blockade as new adjuvant for TB therapies.

Citing Articles

Therapeutic effect of fully human anti-Nrp-1 antibody on non-small cell lung cancer in vivo and in vitro.

Zhang B, Liu Q, Li L, Ye Y, Guo X, Xu W Cancer Immunol Immunother. 2025; 74(2):50.

PMID: 39751948 PMC: 11699024. DOI: 10.1007/s00262-024-03893-1.


Promoter methylation and increased expression of PD-L1 in patients with active tuberculosis.

Tseng Y, Pan S, Huang J, Lee C, Hung J, Hsu P Microb Cell. 2024; 11:278.

PMID: 39081906 PMC: 11287217. DOI: 10.15698/mic2024.07.832.


The evolving landscape of IL-10, IL-22 and IL-26 in pleurisy especially in tuberculous pleurisy.

Niu Q, Wang M, Liu X Respir Res. 2024; 25(1):275.

PMID: 39003443 PMC: 11245850. DOI: 10.1186/s12931-024-02896-x.


Pulmonary Tuberculosis Following Immune Checkpoint Inhibitor Treatment for Recurrent Maxillary Squamous Cell Carcinoma.

Kikuta S, Abe Y, Shinozaki K, Seki N, Kusukawa J Cureus. 2024; 16(1):e53203.

PMID: 38425601 PMC: 10902606. DOI: 10.7759/cureus.53203.


Recent advances in understanding the human host immune response in tuberculous meningitis.

Barnacle J, Davis A, Wilkinson R Front Immunol. 2024; 14:1326651.

PMID: 38264653 PMC: 10803428. DOI: 10.3389/fimmu.2023.1326651.


References
1.
Freeman G, Long A, Iwai Y, Bourque K, Chernova T, Nishimura H . Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000; 192(7):1027-34. PMC: 2193311. DOI: 10.1084/jem.192.7.1027. View

2.
Cho S, Mehra V, Thoma-Uszynski S, Stenger S, Serbina N, Mazzaccaro R . Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci U S A. 2000; 97(22):12210-5. PMC: 17320. DOI: 10.1073/pnas.210391497. View

3.
Loke P, Allison J . PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc Natl Acad Sci U S A. 2003; 100(9):5336-41. PMC: 154346. DOI: 10.1073/pnas.0931259100. View

4.
Lewinsohn D, Heinzel A, Gardner J, Zhu L, Alderson M, Lewinsohn D . Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells. Am J Respir Crit Care Med. 2003; 168(11):1346-52. DOI: 10.1164/rccm.200306-837OC. View

5.
Betts M, Brenchley J, Price D, De Rosa S, Douek D, Roederer M . Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods. 2003; 281(1-2):65-78. DOI: 10.1016/s0022-1759(03)00265-5. View